Rapamycin prevents Parkinson’s in mouse model of incurable neurodegenerative disease

16 septiembre 2015

Rapamycin, a drug that extends lifespan in several species, prevented Parkinson’s disease in middle-age mice that were genetically fated to develop the incurable neurodegenerative disease. While rapamycin did great things for the mice, scientists also got an unexpected plus from the research — a new understanding of the role parkin plays in cellular dynamics, one that challenges the current dogma in PD research and presents new opportunities for drug discovery.